These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 33902570)

  • 1. Connected health for growth hormone treatment research and clinical practice: learnings from different sources of real-world evidence (RWE)-large electronically collected datasets, surveillance studies and individual patients' cases.
    Boman N; Fernandez-Luque L; Koledova E; Kause M; Lapatto R
    BMC Med Inform Decis Mak; 2021 Apr; 21(1):136. PubMed ID: 33902570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adherence and long-term outcomes of therapy in paediatric patients in Greece using the easypod™ electromechanical device for growth hormone treatment: The phase IV multicentre easypod™ connect observational study (ECOS).
    Charmandari E; Vlachopapadopoulou E; Kyritsi EM; Sakellariou D; Koledova E; Nespithal K; Michalacos S
    Growth Horm IGF Res; 2020; 53-54():101336. PubMed ID: 32739654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adherence to treatment in children with growth hormone deficiency, small for gestational age and Turner syndrome in Mexico: results of the Easypod™ connect observational study (ECOS).
    Blanco-López A; Antillón-Ferreira C; Saavedra-Castillo E; Barrientos-Pérez M; Rivero-Escalante H; Flores-Caloca O; Calzada-León R; Rosas-Guerra CC; Koledova E; Chiquete E; Ayala-Estrada A
    J Endocrinol Invest; 2020 Oct; 43(10):1447-1452. PubMed ID: 32239476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of real-world data on growth hormone therapy adherence using a connected injection device.
    Koledova E; Tornincasa V; van Dommelen P
    BMC Med Inform Decis Mak; 2020 Jul; 20(1):176. PubMed ID: 32727461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement of treatment adherence with growth hormone by easypod™ device: experience of an Italian centre.
    Maggio MC; Vergara B; Porcelli P; Corsello G
    Ital J Pediatr; 2018 Sep; 44(1):113. PubMed ID: 30261918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Yearly Height Gain Is Dependent on the Truly Received Dose of Growth Hormone and the Duration of Periods of Poor Adherence: Practical Lessons From the French Easypod™ Connect Multicenter Observational Study.
    Coutant R; Nicolino M; Cammas B; de Buyst V; Tauber M; Hamel JF
    Front Endocrinol (Lausanne); 2021; 12():790169. PubMed ID: 35126310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The adult growth hormone multicentric retrospective observational study: a 24-month Italian experience of adherence monitoring via Easypod™ of recombinant growth hormone treatment in adult GH deficiency.
    Mancini A; Vergani E; Bruno C; Giavoli C; Spaziani M; Isidori AM; Arosio M; Pontecorvi A
    Front Endocrinol (Lausanne); 2023; 14():1298775. PubMed ID: 38027149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adherence to growth hormone (GH) therapy in naïve to treatment GH-deficient children: data of the Italian Cohort from the Easypod Connect Observational Study (ECOS).
    Centonze C; Guzzetti C; Orlando G; Loche S;
    J Endocrinol Invest; 2019 Oct; 42(10):1241-1244. PubMed ID: 30968283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Digital Health in the Management of Pediatric Growth Hormone Therapy - 10 Years of Developments.
    Koledova E; Le Masne Q; Spataru A; Bagha M; Dixon D
    Stud Health Technol Inform; 2021 May; 281():926-930. PubMed ID: 34042809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positive Impact of Targeted Educational Intervention in Children With Low Adherence to Growth Hormone Treatment Identified by Use of the Easypod™ Electronic Auto-injector Device.
    Assefi AR; Roca F; Rubstein A; Chareca C
    Front Med Technol; 2021; 3():609878. PubMed ID: 35047902
    [No Abstract]   [Full Text] [Related]  

  • 11. Adherence and long-term growth outcomes: results from the easypod
    Koledova E; Stoyanov G; Ovbude L; Davies PSW
    Endocr Connect; 2018 Aug; 7(8):914-923. PubMed ID: 29976785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment adherence with the easypod™ growth hormone electronic auto-injector and patient acceptance: survey results from 824 children and their parents.
    Bozzola M; Colle M; Halldin-Stenlid M; Larroque S; Zignani M;
    BMC Endocr Disord; 2011 Feb; 11():4. PubMed ID: 21294891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adherence to Growth Hormone Treatment Using a Connected Device in Latin America: Real-World Exploratory Descriptive Analysis Study.
    Assefi A; van Dommelen P; Arnaud L; Otero C; Fernandez-Luque L; Koledova E; Calliari LE
    JMIR Mhealth Uhealth; 2022 Jan; 10(1):e32626. PubMed ID: 35049518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monitoring of treatment adherence with easypod™ in six Italian centers: a real-world experience.
    Cardinale GM; Pesce S; Ingletto D; Mariano M; Catucci A; Corciulo N; Fidotti E
    Minerva Endocrinol; 2019 Sep; 44(3):246-251. PubMed ID: 30482007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integration of nurse-led virtual reviews with growth hormone device-linked patient adherence information: a mixed methods feasibility study.
    Stokes H; Jones J; Worth C; Nicholson J; Fullwood C; Banerjee I
    Front Endocrinol (Lausanne); 2023; 14():1167854. PubMed ID: 37324260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adherence and long-term outcomes of growth hormone therapy with easypod™ in pediatric subjects: Spanish ECOS study.
    Rodríguez Arnao MD; Rodríguez Sánchez A; Díez López I; Ramírez Fernández J; Bermúdez de la Vega JA; Yeste Fernández D; Chueca Guindulain M; Corripio Collado R; Pérez Sánchez J; Fernández González A
    Endocr Connect; 2019 Sep; 8(9):1240-1249. PubMed ID: 31484160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of machine learning to identify patients at risk of sub-optimal adherence: study based on real-world data from 10,929 children using a connected auto-injector device.
    Spataru A; van Dommelen P; Arnaud L; Le Masne Q; Quarteroni S; Koledova E
    BMC Med Inform Decis Mak; 2022 Jul; 22(1):179. PubMed ID: 35794586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adherence in children with growth hormone deficiency treated with r-hGH and the easypod™ device.
    Loche S; Salerno M; Garofalo P; Cardinale GM; Licenziati MR; Citro G; Caruso Nicoletti M; Cappa M; Longobardi S; Maghnie M; Perrone R
    J Endocrinol Invest; 2016 Dec; 39(12):1419-1424. PubMed ID: 27406716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth hormone treatment adherence in prepubertal and pubertal children with different growth disorders.
    Hartmann K; Ittner J; Müller-Rossberg E; Schönau E; Stephan R; Ullrich KP; Hoppe B; Ramseger R; Brämswig J
    Horm Res Paediatr; 2013; 80(1):1-5. PubMed ID: 23860437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ease of use and acceptability of a new pen device for the administration of growth hormone therapy in pediatric patients: an open-label, uncontrolled usability test.
    Fuchs GS; Mikkelsen S; Knudsen TK; Kappelgaard AM
    Clin Ther; 2009 Dec; 31(12):2906-14. PubMed ID: 20110030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.